Open Access
Med Buccale Chir Buccale
Volume 18, Number 3, août 2012
Page(s) 193 - 210
Section Articles originaux / Original articles
Published online 05 September 2012
  1. Guralnick WC, Berg L. Gelfoam in oral surgery; a report of 250 cases. Oral Surg Oral Med Oral Pathol 1948;1:632-9. [CrossRef] [PubMed] [Google Scholar]
  2. Ifi JC. Risque hémorragique après extractions multiples chez les malades porteurs de diathèses hémorragipares. Actual Odontostomatol 1978;121:45-60. [Google Scholar]
  3. Vinckier F, Vermylen J. Dental extractions in hemophilia: reflections on 10 years' experience. Oral Surg Oral Med Oral Pathol 1985;59:6-9. [CrossRef] [PubMed] [Google Scholar]
  4. Samson J, de Moerloose P, Fiore-Donno G. Les troubles de l’hémostase en médecine dentaire. Rev Mens Suisse Odonto-stomatol 1987;97:1398-402. [Google Scholar]
  5. Gaudy JF, Ankri A, Tager F, El Haddioui A, Bravetti P, Lafont A, Gogly B. Anticoagulants et extractions dentaires. Arch Mal Coeur Vaiss 2005;98:859-66. [PubMed] [Google Scholar]
  6. Sindet-Pedersen S, Stenbjerg S, Ingerslev J. Treatment of bilateral fracture of the mandible in a hemophilic patient with inhibitor to factor VIII. J Oral Maxillofac Surg 1987;45:537-40. [CrossRef] [PubMed] [Google Scholar]
  7. Sumi Y, Shikimori M, Kaneda T, Kitajima T. Multiple extractions in a patient with factor VII deficiency. J Oral Maxillofac Surg 1985;43:382-4. [CrossRef] [PubMed] [Google Scholar]
  8. Halfpenny W, Fraser JS, Adlam DM. Comparison of 2 hemostatic agents for the prevention of postextraction hemorrhage in patients on anticoagulants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:257-9. [CrossRef] [PubMed] [Google Scholar]
  9. Alkan A, Inal S, Yildirim M, Bas B, Agar E. The effects of hemostatic agents on peripheral nerve function: an experimental study. J Oral Maxillofac Surg 2007;65:630-4. [CrossRef] [PubMed] [Google Scholar]
  10. Ibrahim M, Ape C, Young C. A foreign body reaction to surgical mimicking an abscess following cardiac surgery (letter). Eur J Cardiothorac Surg 2002;22:489-90. [CrossRef] [PubMed] [Google Scholar]
  11. Kothbauer KF, Jallo GI, Siffert J, Jimenez E, Allen JC, Epstein FJ. Foreign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases. J Neurosurg 2001;95:503-6. [CrossRef] [Google Scholar]
  12. Lucas ON. Inactivation of thrombin by oxidized cellulose. J Oral Ther Pharmacol 1967;3:262-8. [PubMed] [Google Scholar]
  13. Correll JT, Wise EC. The stability of thrombin, penicillin, or streptomycin, in the presence of gelatin sponge, oxidized cellulose or each other. Surg Gynecol Obstet 1947;85:211-3. [PubMed] [Google Scholar]
  14. Lattes R, Frantz VK. Absorbable gauze in bone surgery: experimental studies suggesting clinical application in reconstruction of joints. Ann Surg 1946;124:28-39. [CrossRef] [Google Scholar]
  15. McBee WL, Koerner KR. Review of hemostatic agents used in dentistry. Dent Today 2005;24:62-5; quiz 65, 61. [PubMed] [Google Scholar]
  16. Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J 2004;13:S89-96. [CrossRef] [PubMed] [Google Scholar]
  17. Mullins RJ, Richards C, Walker T. Allergic reactions to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons. Aust N Z J Ophthalmol 1996;24:257-60. [CrossRef] [Google Scholar]
  18. Basu S, Marini CP, Bauman FG, Shirazian D, Damiani P, Robertazzi R, Jacobowitz IJ, Acinapura A, Cunningham Jr JN. Comparative study of biological glues: cryoprecipitate glue, two-component fibrin sealant, and “French” glue. Ann Thorac Surg 1995;60:1255-62. [CrossRef] [PubMed] [Google Scholar]
  19. Kirsch M, Ginat M, Lecerf L, Houel R, Loisance D. Aortic wall alterations after use of gelatin-resorcinol-formalin glue. Ann Thorac Surg 2002;73:642-4. [CrossRef] [PubMed] [Google Scholar]
  20. Germain M, Larrieu H, Gremillet C. Une amélioration des colles biologiques. Nouv Presse Med 1977;6:1661 [Google Scholar]
  21. Bingley JA, Gardner MA, Stafford EG, Mau TK, Pohlner PG, Tam RK, Jalali H, Tesar PJ, O'Brien MF. Late complications of tissue glues in aortic surgery. Ann Thorac Surg 2000;69:1764-8. [CrossRef] [PubMed] [Google Scholar]
  22. Braunwald NS, Gay W, Tatooles CJ. Evaluation of crosslinked gelatin as a tissue adhesive and hemostatic agent: an experimental study. Surgery 1966;59:1024-30. [PubMed] [Google Scholar]
  23. Coover H, Joyner F, Sheare T, Wicker T. Chemistry and performance of cyanoacrylate adhesives. Soc Plastic Engrs J 1959;15:413. [Google Scholar]
  24. Causton B, Cahn R, Haasen P, Kramer E. Medical and dental materials (pp. 291-2). In: Materials science and technology: a comprehensive treatment. VCH Publishers Inc., New York, 1992. [Google Scholar]
  25. Seewald S, Groth S, Sriram PV, Xikun H, Akaraviputh T, Mendoza G, Brand B, Seitz U, Thonke F, Soehendra N. Endoscopic treatment of biliary leakage with n-butyl-2 cyanoacrylate. Gastrointest Endosc 2002;56:916-9. [CrossRef] [PubMed] [Google Scholar]
  26. Soehendra N, Nam VC, Grimm H, Kempeneers I. Endoscopic obliteration of large esophagogastric varices with bucrylate. Endoscopy 1986;18:25-6. [CrossRef] [PubMed] [Google Scholar]
  27. Martins FP, Macedo EP, Paulo GA, Nakao FS, Ardengh JC, Ferrari AP. Endoscopic follow-up of cyanoacrylate obliteration of gastric varices. Arq Gastroenterol 2009;46: 81-4. [CrossRef] [PubMed] [Google Scholar]
  28. Cipolletta L, Zambelli A, Bianco MA, De Grazia F,Meucci C, Lupinacci G, Salerno R, Piscopo R, Marmo R, Orsini L, Rotondano G. Acrylate glue injection for acutely bleeding oesophageal varices: a prospective cohort study. Dig Liver Dis 2009;41:729-34. [CrossRef] [PubMed] [Google Scholar]
  29. Cousin GC. Accidental application of cyanoacrylate to the mouth. Br Dent J 1990;169:293-4. [CrossRef] [PubMed] [Google Scholar]
  30. Yilmaz T, Yilmaz G. Accidental cyanoacrylate glue ingestion. Int J Pediatr Otorhinolaryngol 2005;69:853-5. [CrossRef] [PubMed] [Google Scholar]
  31. Bhaskar SN, Frisch J, Cutright DE, Margetis P. Effect of butyl cyanoacrylate on the healing of extraction wounds. Oral Surg Oral Med Oral Pathol 1967;24:604-16. [CrossRef] [PubMed] [Google Scholar]
  32. Greer JrRO. Studies concerning the histotoxicity of isobutyl-2-cyanoacrylate tissue adhesive when employed as an oral hemostat. Oral Surg Oral Med Oral Pathol 1975;40:659-69. [CrossRef] [PubMed] [Google Scholar]
  33. Bergel S. Über Wirkungen des fibrins. Dtsch Med Wochenschr 1909;35:633. [CrossRef] [Google Scholar]
  34. Grey E. Fibrin as a hemostatic in cerebral surgery. Surg Gynecol Obstet 1915;21:452. [Google Scholar]
  35. Harvey S. The use of fibrin papers and forms in surgery. Boston Med Surg J 1916;174:658. [CrossRef] [Google Scholar]
  36. Young J, Medawer P. Fibrin suture of peripheral nerves. Lancet 1940;239:126. [CrossRef] [Google Scholar]
  37. Cronkite E, Lozner E, Deaver J. Use of thrombin and fibrinogen in skin grafting. J Am Med Assoc 1944;124:976. [CrossRef] [Google Scholar]
  38. Tedrick R, Warner E. Fibrin fixation of skin transplants. Surgery 1944;15:19. [Google Scholar]
  39. Matras H. Fibrin seal: the state of the art. J Oral Maxillofac Surg 1985;43:605-11. [CrossRef] [PubMed] [Google Scholar]
  40. Sierra DH. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomater Appl 1993;7:309-52. [CrossRef] [PubMed] [Google Scholar]
  41. Matras H. Die wirkungen verschiener fibrin präparate auf kontinuitätstrennungen der rattenhaut. Osterr Z Stomatol 1970;67:338-59. [PubMed] [Google Scholar]
  42. Pool JG, Gershgold EJ, Pappenhagen AR. High-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature 1964;203:312. [CrossRef] [Google Scholar]
  43. Matras H, Dinges HP, Lassmann H, Mamoli B. Zur nahtlosen interfaszikulären nerventransplantation im tierexperiment. Wien Med Wochenschr 1972;122:517-23. [PubMed] [Google Scholar]
  44. Kurderna H, Matras H. Die klinische anwendung der klebung von nervenanastomosen bie der rekonstruktion verletzter peripherer nerven. Wien Klin Wochenschr 1975;87:495-6. [Google Scholar]
  45. Kovacs B, Toth K, Kerenyi G. Post-extraction hemostasis during coumarin anticoagulant therapy with a locally applied coagulation-active substance. Int J Oral Surg 1976;5:3-7. [CrossRef] [PubMed] [Google Scholar]
  46. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N Engl J Med 1996;334:1685-90. [CrossRef] [Google Scholar]
  47. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP, Petersen LR. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995;333:1721-5. [CrossRef] [PubMed] [Google Scholar]
  48. Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg 2001;182:1S-7S. [CrossRef] [PubMed] [Google Scholar]
  49. Wilson S, Pell P, Donegan E. HIV-1 transmission following the use of cryoprecipitated fibrinogen as gel/adhesive (abstract). Transfusion 1991; (Suppl 5):31. [Google Scholar]
  50. Fattahi T, Mohan M, Caldwell GT. Clinical applications of fibrin sealants. J Oral Maxillofac Surg 2004;62:218-24. [CrossRef] [PubMed] [Google Scholar]
  51. Ofosu FA, Freedman J, Semple JW. Plasma-derived biological medicines used to promote haemostasis. Thromb Haemost 2008;99:851-62. [PubMed] [Google Scholar]
  52. Wai Y, Tsui V, Peng Z, Richardson R, Oreopoulos D, Tarlo SM. Anaphylaxis from topical bovine thrombin (Thrombostat) during haemodialysis and evaluation of sensitization among a dialysis population. Clin Exp Allergy 2003;33:1730-4. [CrossRef] [PubMed] [Google Scholar]
  53. Jankowski R, Beaudouin E, Kanny G, Wayoff M, Moneret-Vautrin DA. Accidents d'hypersensibilité à la thrombine, consécutifs à l'emploi de colles biologiques. Ann Otolaryngol Chir Cervicofac 1992;109:95-9. [PubMed] [Google Scholar]
  54. Tadokoro K, Ohtoshi T, Takafuji S, Nakajima K, Suzuki S, Yamamoto K, Ito K, Miyamoto T, Muranaka M. Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studies. J Allergy Clin Immunol 1991;88:620-9. [CrossRef] [PubMed] [Google Scholar]
  55. Kanchuger MS, Eide TR, Manecke GR, Hartman A, Poppers PJ. The hemodynamic effects of topical fibrin glue during cardiac operations. J Cardiothorac Anesth 1989;3:745-7. [CrossRef] [PubMed] [Google Scholar]
  56. Kober BJ, Scheule AM, Voth V, Deschner N, Schmid E, Ziemer G. Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant. Anesth Analg 2008;107:406-9. [CrossRef] [PubMed] [Google Scholar]
  57. Shirai T, Shimota H, Chida K, Sano S, Takeuchi Y, Yasueda H. Anaphylaxis to aprotinin in fibrin sealant. Intern Med 2005;44:1088-9. [CrossRef] [PubMed] [Google Scholar]
  58. Beierlein W, Scheule AM, Antoniadis G, Braun C, Schosser R. An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion 2000;40:302-5. [CrossRef] [PubMed] [Google Scholar]
  59. Berruyer M, Amiral J, French P, Belleville J, Bastien O, Clerc J, Kassir A, Estanove S, Dechavanne M. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors. J Thorac Cardiovasc Surg 1993;105:892-7. [Google Scholar]
  60. Streiff MB, Ness PM. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002;42:18-26. [CrossRef] [PubMed] [Google Scholar]
  61. Zumberg MS, Waples JM, Kao KJ, Lottenberg R. Management of a patient with a mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant. Am J Hematol 2000;64:59-63. [CrossRef] [PubMed] [Google Scholar]
  62. Ortel TL. Clinical and laboratory manifestations of anti-factor V antibodies. J Lab Clin Med 1999;133:326-34. [CrossRef] [PubMed] [Google Scholar]
  63. Joch C, Witzke G, Groner A. Clinical safety of fibrin sealants. Poster session presented at the IX World congress of Cardiothoracic Surgeons; 1999 November 14–17; Lisbon, Portugal. [Google Scholar]
  64. Joch C. The safety of fibrin sealants. Cardiovasc Surg 2003;11: 23-8. [CrossRef] [PubMed] [Google Scholar]
  65. Hino M, Yamamura R, Nishiki S, Ohta K, Yamane T, Takubo T, Tatsumi N. Human parvovirus B19-induced aplastic crisis in a patient treated with fibrin sealant. Rinsho Ketsueki 1999;40:145-9. [PubMed] [Google Scholar]
  66. Hino M, Ishiko O, Honda KI, Yamane T, Ohta K, Takubo T, Tatsumi N. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 2000;108:194-5. [CrossRef] [PubMed] [Google Scholar]
  67. Honda K, Ishiko O, Tsujimura A, Hino M, Hirai K, Itoh F, Tanaka T, Ogita S. Neutropenia accompanying parvovirus B19 infection after gynecologic surgery. Acta Haematol 2000;103:186-90. [CrossRef] [PubMed] [Google Scholar]
  68. Enoki C, Higashi S, Oohata M, Tanaka T. A case of acute erythroblastic anemia due to infection with human parvovirus B19 after coronary artery bypass grafting. Kyobu Geka 2002;55:116-9. [PubMed] [Google Scholar]
  69. Kawamura M, Sawafuji M, Watanabe M, Horinouchi H, Kobayashi K. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg 2002;73:1098-100. [CrossRef] [PubMed] [Google Scholar]
  70. Flemming I. Fibrin glue in face lifts. Facial Plast Surg 1992;8: 79-88. [CrossRef] [PubMed] [Google Scholar]
  71. Grossman JA, Capraro PA, Burneikis V. Minimizing complications in the use of fibrin sealant in aesthetic facial procedures. Aesthet Surg J 2001;21:32-9. [CrossRef] [PubMed] [Google Scholar]
  72. Radosevich M, Goubran HI, Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang 1997;72:133-43. [CrossRef] [PubMed] [Google Scholar]
  73. Patatanian E, Fugate SE. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction. Ann Pharmacother 2006;40:2205-10. [CrossRef] [PubMed] [Google Scholar]
  74. Carter G, Goss A, Lloyd J, Tocchetti R. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study. J Oral Maxillofac Surg 2003;61:1432-5. [CrossRef] [PubMed] [Google Scholar]
  75. Benoliel R, Leviner E, Katz J, Tzukert A. Dental treatment for the patient on anticoagulant therapy: prothrombin time value - what difference does it make? Oral Surg Oral Med Oral Pathol 1986;62:149-51. [CrossRef] [PubMed] [Google Scholar]
  76. Samson J, Mauprivez C, Alantar A, Perrin D, Tazi M. Prise en charge des patients sous agents antiplaquettaires en odontostomatologie. Recommandations. Med Buccale Chir Buccale 2005;11:55-76. [Google Scholar]
  77. Gaudy JF, Arreto CD. Manuel d'analgésie en odontostomatologie (p. 205). 2e éd. Masson, Paris, 2005. [Google Scholar]
  78. Archer WH, Zubrow HJ. Fatal hemorrhage following regional anesthesia for operative dentistry in a hemophiliac. Oral Surg Oral Med Oral Pathol 1954;7:464-70. [CrossRef] [PubMed] [Google Scholar]
  79. Johnson WT, Leary JM. Management of dental patients with bleeding disorders: review and update. Oral Surg Oral Med Oral Pathol 1988;66:297-303. [CrossRef] [PubMed] [Google Scholar]
  80. Wynn RL, Bergman SA. Clopidogrel (Plavix): dental considerations of an antiplatelet drug. Gen Dent 2001;49:564-8. [PubMed] [Google Scholar]
  81. Eurin B, Fischler M. Intubation trachéale (p. 154). Masson, Paris, 1993. [Google Scholar]
  82. Wahl MJ. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc 2000;131:77-81. [PubMed] [Google Scholar]
  83. Samson J, Fiore-Donno G. Extraction dentaires et troubles de l’hémostase. Med Hyg 1980;38:1437-8. [Google Scholar]
  84. Bernard JP, Lombardi T, Samson J. Use of a fibrin sealant for dental extractions in irradiated jaws (pp. 172-5). In: G. Schlag/H Redl Eds. Fibrin sealant in operative medicine, plastic surgery, maxillofacial and dental surgery, Springer-Verlag, Berlin, 1994. [Google Scholar]
  85. Niamtu 3rd J. Near-fatal airway obstruction after routine implant placement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:597-600. [Google Scholar]
  86. Sakamoto E, Miller R, Stratigos GT, Arthur A. Serious postextraction hemorrhage into the submandibular space: report of case. J Am Dent Assoc 1975;90:654-8. [PubMed] [Google Scholar]
  87. Funayama M, Kumagai T, Saito K, Watanabe T. Asphyxial death caused by postextraction hematoma. Am J Forensic Med Pathol 1994;15:87-90. [CrossRef] [PubMed] [Google Scholar]
  88. Gaudy JF. Une nouvelle technique d’hémostase en odontostomatologie. Inf Dent 1986;68:3301-7. [PubMed] [Google Scholar]
  89. Heit JA. Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 2001;12:81-7. [CrossRef] [PubMed] [Google Scholar]
  90. Ziffer AM, Scopp IW, Beck J, Baum J, Berger AR. Profound bleeding after dental extractions during dicumarol therapy. N Engl J Med 1957;256:351-3. [CrossRef] [PubMed] [Google Scholar]
  91. Mehra P, Cottrell DA, Bestgen S, Booth DF. A nomogram for management of heparin therapy in the high-risk chronically anticoagulated oral surgery patient. J Oral Maxillofac Surg 2000;57:198-203. [CrossRef] [Google Scholar]
  92. Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AG, Bates SM, Desjardins L, Douketis J, Kahn SR, Solymoss S, Wells PS. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004;110: 1658-63. [CrossRef] [PubMed] [Google Scholar]
  93. Sacco R, Sacco M, Carpenedo M, Mannucci PM. Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different intensity targets. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104:e18-21. [CrossRef] [Google Scholar]
  94. Pototski M, Amenabar JM. Dental management of patients receiving anticoagulation or antiplatelet treatment. J Oral Sci 2007;49:253-8. [CrossRef] [PubMed] [Google Scholar]
  95. De Mello G, Gangloff P, Djiane P, Galeazzi J-M, Iung B, Lefevre B, Lepouse C, Mariottini JP, Monsuez JJ, Nawrocki L, Pontis JL, Samama M, Schved JF, Torres JH. Recommandations pour la prise en charge des patients sous traitement anti-vitamines K en chirurgie bucco-dentaire. Med Buccale Chir Buccale 2006;12:187-212. [Google Scholar]
  96. Perry DJ, Noakes TJ, Helliwell PS. Guidelines for the management of patients on oral anticoagulants requiring dental surgery. Br Dent J 2007;203:389-93. [CrossRef] [PubMed] [Google Scholar]
  97. Beirne OR, Koehler JR. Surgical management of patients on warfarin sodium. J Oral Maxillofac Surg 1996;54:1115-8. [CrossRef] [PubMed] [Google Scholar]
  98. Forseth M, O'Grady K, Toriumi DM. The current status of cyanoacrylate and fibrin tissue adhesives. J Long Term Eff Med Implants 1992;2:221-33. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.